Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era

Otitis Media in Fully Vaccinated Preschool Children in the Pneumococcal Conjugate Vaccine Era

Objectives. To evaluate the effect of pneumococcal conjugate vaccine (PCV13) on the burden of acute otitis media (AOM) and to evaluate the characteristics of AOM versus otitis media with effusion (OME) in the 2 PCV periods. Methods. A cohort of fully vaccinated children aged 18 to 60 months diagnose...

Full description

Bibliographic Details
Main Authors:	Saurabh Talathi MD, MPH, Neha Gupta MD, Swathi Sethuram MD, Shefali Khanna MD, Yekaterina Sitnitskaya MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2017-12-01
Series:	Global Pediatric Health
Online Access:	https://doi.org/10.1177/2333794X17749668

Similar Items

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
by: Thijs W. Hoffman, MD, et al.
Published: (2020-06-01)

Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era
by: Chih-Ho Chen, et al.
Published: (2020-12-01)

Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine.
by: Corinne Levy, et al.
Published: (2019-01-01)

Pneumococcal antibody concentrations of subjects in communities fully or partially vaccinated with a seven-valent pneumococcal conjugate vaccine.
by: Martin O C Ota, et al.
Published: (2012-01-01)

Adult Otogenic Meningitis in the Pneumococcal Conjugated Vaccines Era
by: Tal Marom, et al.
Published: (2020-01-01)

Biofilm-Forming Bacteria Implicated in Complex Otitis Media in Children in the Post-Heptavalent Pneumococcal Conjugate Vaccine (PCV7) Era
by: Anastasios Ioannidis, et al.
Published: (2023-02-01)

Serotypes in Adult Pneumococcal Pneumonia in Spain in the Era of Conjugate Vaccines
by: Lucía Fernández-Delgado, et al.
Published: (2021-10-01)

Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
by: Patricia Izurieta, et al.
Published: (2022-01-01)

The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media
by: Tal Marom, et al.
Published: (2017-10-01)

Contiguous Osteomyelitis of Distal Extremities in Children
by: Akshay Vivek Nandavar MD, et al.
Published: (2021-02-01)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
by: Chiara Scelfo, et al.
Published: (2021-04-01)

13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
by: V. K. Tatochenko, et al.
Published: (2012-03-01)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
by: Michael Pichichero, et al.
Published: (2023-12-01)

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease
by: Tsega Temtem MD, et al.
Published: (2019-05-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
by: Carina Valente, et al.
Published: (2012-01-01)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
by: Grant A. Mackenzie, et al.
Published: (2022-01-01)

Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage
by: Christopher Clarke, et al.
Published: (2017-07-01)

Influence of Pneumococcal Conjugate Vaccine on Acute Otitis Media with Severe Middle Ear Inflammation: A Retrospective Multicenter Study.
by: Hirotoshi Sugino, et al.
Published: (2015-01-01)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
by: James T. Peterson, et al.
Published: (2019-03-01)

The effectiveness of pneumococcal vaccination and dynamics of acute otitis media incidence in children
by: G. M. Letifov, et al.
Published: (2019-11-01)

Budgetary Impact of 20-Valent Pneumococcal Conjugate Vaccine Use for Adult Expatriates Living in Dubai
by: Mostafa Zayed, MSc, et al.
Published: (2023-01-01)

Occult bacteremia in children with simple febrile seizure in the post-pneumococcal conjugate vaccine era
by: Gwan Shik Yoon, et al.
Published: (2021-12-01)

Childhood meningitis in Kuwait in the era of post pneumococcal conjugate vaccination: A multicenter study
by: Hussain Sadeq, et al.
Published: (2017-11-01)

Incidence of pneumonia is not reduced by pneumococcal conjugate vaccine
by: Sona Chowdhary, et al.
Published: (2008-10-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Economic evaluation of pneumococcal conjugate vaccination in The Gambia
by: Kim Sun-Young, et al.
Published: (2010-09-01)

Herd protection induced by pneumococcal conjugate vaccine
by: Keith P Klugman
Published: (2014-07-01)

13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017-03-01)

Conjugate pneumococcal vaccines: Need and choice in India
by: Akash Malik, et al.
Published: (2013-01-01)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
by: Anna M.M. van Deursen, et al.
Published: (2012-11-01)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
by: Bhavna Dhingra, et al.
Published: (2020-12-01)

Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh.
by: Abdullah H Baqui, et al.
Published: (2020-01-01)

From individual to herd protection with pneumococcal vaccines: the contribution of the Cuban pneumococcal conjugate vaccine implementation strategy
by: Nivaldo Linares-Pérez, et al.
Published: (2017-07-01)

Effectiveness of 10-valent pneumococcal conjugate vaccine against vaccine-type invasive pneumococcal disease in Pakistan
by: Atif Riaz, et al.
Published: (2019-03-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
by: Hiroaki Takeda, et al.
Published: (2019-01-01)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
by: Anita H J van den Biggelaar, et al.
Published: (2017-01-01)

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece
by: George Gourzoulidis, et al.
Published: (2023-09-01)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
by: Edmunds W John, et al.
Published: (2010-04-01)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019-04-01)

Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
by: Tinevimbo Shiri, DrPhD, et al.
Published: (2017-01-01)